Minoxidil in the treatment of androgenetic alopecia. Issue 5 (28th August 2018)

• Record Type: Journal Article
• Authors: Goren, Andy; Naccarato, Ty
• Is Part Of: Dermatologic therapy. Volume 31:Issue 5(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-08-28
• Subjects: alopecia -- hair disorders -- minoxidil; Skin -- Diseases -- Periodicals; Dermatology -- Periodicals; 616.5
• DOI: 10.1111/dth.12686
• Languages: English
• ISSNs: 1396-0296

Abstract

Abstract: The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA (also known as pattern hair loss). Minoxidil is the only topical drug for the treatment of both female and male pattern hair loss. In the US, minoxidil is approved over‐the‐counter (OTC) at a maximum concentration of 5%. In this review, we summarize the findings of the pivotal studies used in support of the drug's approval as well as recent discoveries and novel developments in the use of minoxidil for the treatment of AGA.